RALEIGH, N.C.--(BUSINESS WIRE)--Ajinomoto AminoScience LLC (AAS) today announced the availability of a case study profiling how one global pharmaceutical company relied on the CorynexTM Recombinant Protein Expression System to simplify the development of recombinant proteins.
